David Main - Net Worth and Insider Trading
David Main Net Worth
The estimated net worth of David Main is at least $12,484 dollars as of 2024-09-21. David Main is the President and CEO of Neoleukin Therapeutics Inc and owns about 3,577 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $12,484. Details can be seen in David Main's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Main has not made any transactions after 2017-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Main
David Main Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Main owns 1 companies in total, including Neoleukin Therapeutics Inc (NLTX) .
Click here to see the complete history of David Main’s form 4 insider trades.
Insider Ownership Summary of David Main
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2017-06-05 | director & President and CEO |
David Main Latest Holdings Summary
David Main currently owns a total of 1 stock. David Main owns 3,577 shares of Neoleukin Therapeutics Inc (NLTX) as of June 5, 2017, with a value of $12,484.
Latest Holdings of David Main
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2017-06-05 | 3,577 | 3.49 | 12,484 |
Holding Weightings of David Main
David Main Form 4 Trading Tracker
According to the SEC Form 4 filings, David Main has made a total of 0 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 781 shares on June 5, 2017, which brought David Main around $207,188.
Insider Trading History of David Main
- 1
David Main Trading Performance
David Main Ownership Network
David Main Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
David Main is the director & President and CEO of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, David Main made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , a net sale of 3,769 shares made by Priti Patel , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 255 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,013 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
David Main Mailing Address
Above is the net worth, insider trading, and ownership report for David Main. You might contact David Main via mailing address: 450 - 887 Great Northern Way, Vancouver A1 V5t 4t5.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
